Switching from Conventional Fibrates to Pemafibrate Has Beneficial Effects on the Renal Function of Diabetic Subjects with Chronic Kidney Disease
CONCLUSION: A switch to pemafibrate may be associated with an elevation in eGFR, but to a lesser extent in patients with poor renal function.PMID:38419467 | DOI:10.4093/dmj.2023.0370 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - February 29, 2024 Category: Endocrinology Authors: Rimi Izumihara Hiroshi Nomoto Kenichi Kito Yuki Yamauchi Kazuno Omori Yui Shibayama Shingo Yanagiya Aika Miya Hiraku Kameda Kyu Yong Cho So Nagai Ichiro Sakuma Akinobu Nakamura Tatsuya Atsumi PARM-T2D Study Group Source Type: research
Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus
CONCLUSION: In real-world clinical practice in Korea, the change of insulin regimen to IDegAsp was associated with an improvement in glycemic control without increase of hypoglycemia, supporting the use of IDegAsp for patients with T2DM uncontrolled with basal or premix insulin.PMID:38410023 | DOI:10.4093/dmj.2023.0297 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - February 27, 2024 Category: Endocrinology Authors: Shinae Kang Yu-Bae Ahn Tae Keun Oh Won-Young Lee Sung Wan Chun Boram Bae Amine Dahaoui Jin Sook Jeong Sungeun Jung Hak Chul Jang Source Type: research
Does the Relationship of the Autonomic Symptoms Questionnaire COMPASS 31 with Cardiovascular Autonomic Tests Differ between Type 1 and Type 2 Diabetes Mellitus?
CONCLUSION: COMPASS 31 is more weakly related to CAN in T2DM than in T1DM, with a fair diagnostic accuracy for confirmed CAN only in T1DM. This difference supports a multifactorial origin of symptoms and should be considered when using COMPASS 31.PMID:38408489 | DOI:10.4093/dmj.2023.0301 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - February 26, 2024 Category: Endocrinology Authors: Ilenia D'Ippolito Marika Menduni Cinzia D'Amato Aikaterini Andreadi Davide Lauro Vincenza Spallone Source Type: research
Diabetes Promotes Myocardial Fibrosis via AMPK/EZH2/PPAR- γ Signaling Pathway
CONCLUSION: Our data revealed an AMPK/EZH2/PPAR-γ signal pathway is involved in HG-induced cardiac fibrosis.PMID:38408883 | DOI:10.4093/dmj.2023.0031 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - February 26, 2024 Category: Endocrinology Authors: Shan-Shan Li Lu Pan Zhen-Ye Zhang Meng-Dan Zhou Xu-Fei Chen Ling-Ling Qian Min Dai Juan Lu Zhi-Ming Yu Shipeng Dang Ru-Xing Wang Source Type: research
Risk of Cardiovascular Disease according to Baseline Low-Density Lipoprotein Cholesterol Level in Different Age Groups in Korean Diabetes Population: A Cohort Study
CONCLUSION: The effect of LDL-C on the risk of CVD differs depending on the age of the population with DM.PMID:38403889 | DOI:10.4093/dmj.2022.0443 (Source: Diabetes and Metabolism Journal)
Source: Diabetes and Metabolism Journal - February 25, 2024 Category: Endocrinology Authors: Tae Kyung Yoo Kyung-Do Han Eun-Jung Rhee Won-Young Lee Source Type: research
